Influence of socio-health variables on the cognitive state of mind of the geriatric patients of a health centre;Influencia de variables socio-sanitarias en la situación del estado cognitivo y de ánimo en los pacientes geriátricos de un centro de salud

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue 2, 2003, Pages 211-223

  Hervás, Adolfo ^a,b   Arizcuren, M A ^b   Garcia de Jalon E ^b   Tiberio, G ^b   Forcen T ^a  

^a Centro de Salud de Tafalla   (Spain)

^b Resid Geriatrica Landazabal ^*

Author keywords

Elderly people; Geriatric scale of depression; Mini mental state examination; Primary care

Indexed keywords

PSYCHOTROPIC AGENT;

AGE; AGED; ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; COGNITION; COGNITIVE DEFECT; COGNITIVE MINIEXAM; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; EDUCATION; FEMALE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HOME CARE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSOMNIA; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NURSING HOME; OSTEOARTHRITIS; OUTPATIENT; POLYPHARMACY; PRIMARY MEDICAL CARE; SCORING SYSTEM; SOCIAL ASPECT; SOCIOHEALTH FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; COGNITION DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS INDICATORS; HUMANS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS;

EID: 0041689864     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. IMSERSO. La tercera edad en España: aspectos cuantitativos. Proyecciones de la población española de 60 y más años para el periodo 1986-2010. Madrid, Ministerio de asuntos sociales, 1990.
2. KATZMAN R. The prevalence and malignancy of Alzheimer's disease. A mayor killer. Arch Neurol 1976; 33: 217-218.
3. Review: Several risk factors are associated with functional status decline in community-living older persons. ACP Journal Club 1999; 131: 76.
4. STUCK AE, WALTHERT JM, NIKOLAUS T, BULA CJ, HOHMANN C, BEDK JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999; 48: 445-469.
5. LOBO A, LAUNER LJ, FRATIGLIONI L, ANDERSEN K, DI CARLO A, BRETELER MM et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54 (11 Suppl 5): S4-S9.
6. LOBO A, DEWEY ME, COPELAND JRM, DÍA JL, SAZ P. The prevalence of dementia among elderly people living in Zaragoza and Liverpool. Psycol Med 1992; 22: 239-243.
7. LOBO A, SAZ P, MARCOS G, DIA JL, DE LA CÁMARA C. The prevalence of dementia and depression in the elderly comunity in a Sourthen European population: The Zaragoza Study. Arch Gen Psychiatry 1995; 52: 497-506.
8. LOPEZ POUSA S, LUNAS REGLA J, VILALTA FRANCH J, LOZANO FERNANDEZ DE PINEDO L. Prevalencia de la demencia en Girona. Neurología 1995; 10: 189-193.
9. VILALTA-FRANCH J, LOPEZ-POUSA S, LLINAS-REGLA J. Prevalencia de demencias en un área rural. Un estudio en Girona. Rev Neurol 2000; 30: 1026-1032.
10. MANUBENS JM, MARTINEZ-LAGE JM, LACRUZ F, MURUZABAL J, LARUMBE R, GUARCH C et al. Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain. Neuroepidemiology 1995; 14: 155-164.
11. EVANS DA, FUNKENSTEIN HH, ALBERT MS, SCHERR PA, COOK NR, CHOWN MJ et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551-2556.
12. HEBERT LE, SCHERR PA, BECKETT LA. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995; 273: 1354-1359.
13. MANUBENS JM, MARTÍNEZ-LAGE P, MARTÍNEZ LAGE JM, LARUMBE R, MURUZÁBAL J, GUARCH C et al. Variación de las puntuaciones en el Mini-Mental State con la edad y nivel educativo. Datos normalizados en la población mayor de 70 años de Pamplona. Neurología 1998; 13: 111-119.
14. VAN DUIJN CM, CLAYTON D, CHANDRA V, FLATIGLIONI L, GRAVES AB, HEYMAN A et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991; 20: S13-S20.
15. HENDERSON AS, EASTEAL S, JORM AF. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 1995; 346: 1387-1390.
16. POLVIKOSKI T, SULKAVA R, HALTIA M, KAINULAINEN K, VUORIO A, VERKKONIEMI A et al. Apolipoprotein E, dementia and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 333: 1242-1247.
17. EVANS DA, BECKETT LA, FIELD TS, FENG L, ALBERT MS, BENNETT DA et al. Apolipoprotein E ? 4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997; 277: 822-824.
18. OTT A, STOLK RP, VAN HARSKAMP F, POLS HA, HOFMAN A, BRETELER MM. Diabetes mellitus and the risk of dementia. The Rotterdam study. Neurology 1999; 53: 1937-1942.
19. LOVESTONE S. Diabetes and dementia: is the brain another site of end-organ damage? [editorial; comment]. Neurology 1999; 53: 1907-1909.
20. MORONEY JT, TANG MX, BERGLUND L, SMALL M, MERCHANT C, BELL K et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999; 282: 254-260.
21. TZOURIO C, DUFOUIL C, DUCIMETIERE P, ALPEROVITCH A. Cognitive decline in individuals with high blood pressure. A longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 1999; 53:1948-1952.
22. Antihypertensive treatment may have reduced the rate of dementia in older patients with isolated systolic hypertension. ACP Journal Club 1999; 130: 57.
23. FORETTE F, SEUX ML, STAESSEN JA, THIJS L, BIRKENHAGER WH, BABARSKIENE MR et al. For the Syst-Eur Investigators. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1351.
24. SCHERR PA, HEBERT LE, SMITH LA, EVANS DA. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol 1991; 134:1303-1315.
25. KIVIPELTO M, HELKALA EL, LAAKSO MP, HÄNNINEN T, HALLIKAINEN M, ALHAINEN K et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br Med J 2001; 322: 1447-1451.
26. FRATIGLIONI L, GRUT M, FORSELL Y, VIITANEN M, GRAFSTROM M, HOLMEN K et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex and education. Neurology 1991; 41:1886-1892.
27. MARTINEZ LAGE JM, MARTINEZ-LAGE P. Education, brain reserve, and risk factors for dementia and Alzheimer disease. Med Clin (Barc) 2001; 116: 418-421.
28. GARCÍA GARCÍA FJ, SÁNCHEZ AYALA MI, PÉREZ MARTIN A, MARTÍN CORREA E, MARSAL ALONSO C, RODRÍGUEZ FERRER G et al. Prevalencia de demencia y sus subtipos principales en sujetos mayores de 65 años: impacto de la ocupación y del nivel educacional. El estudio Toledo. Med Clin (Barc) 2001; 116: 401-407.
29. VILALTA-FRANCH J, LLINAS-REGLA J, LÓPEZ-POUSA S. Cognition and depression. Rev Neurol 1998; 27: 581-584.
30. VILALTA-FRANCH J, LOPEZ-POUSA S, LLINAS-REGLA J. Prevalence of depressive disorders in dementia. Rev Neurol 1998; 26: 57-60.
31. VILALTA-FRANCH J, LLINAS-REGLA J, LÓPEZ-POUSA S. Depresión y demencia: un estudio caso-control. Rev Neurol 1999; 29: 599-603.
32. RIED LD, JOHNSON RE, GETTMAN DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc 1998; 46: 71-76.
33. PATERNITI S, DUFOUIL C, ALPEROVITCH A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol 2002; 22: 285-293.
34. LEIPZIG RM, CUMMING RG, TINETTI ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-39.
35. A clinical prediction tool that includes modifiable risk factors predicted functional decline in elderly women. ACP Journal Club 2000; 133: 77
36. SARKISIAN CA, LIU H, GUTIERREZ PR, SEELEY DG, CUMMINGS SR, MANGIONE CM. For the Study of Osteoporotic Fractures Research Group. Modifiable risk factors predict functional decline among older women: a prospectively validated clinical prediction tool. J Am Geriatr Soc 2000; 48: 170-178.
37. FOLSTEIN MF, FOLSTEIN SE, MCHUGHPR. "Mini Mental State": a practical meted for grading the cognitive state of patients for the clinician . J Psychiatr Res 1975; 12: 189-198.
38. LOBO A, SAZ P, MARCO C. Demencias. En: Bulbena A, Berrios G.E., Fernández de Larrinoa P. Medición clínica en psiquiatría y psicología. Barcelona. Editorial Masson, 2000: 335-347.
39. MULLIGAN R, MACKINNON A, JORM AF, GIANNAKOPOULOS P, MICHEL JP. A comparison of alternative methods of screening for dementia in clinical settings. Arch Neurol 1996; 53: 532-536.
40. KAPLAN H, SADOCK B. Tratado de psiquiatría. Delirium, demencia, trastornos amnésicos y otros trastornos cognitivos. Buenos Aires. Editorial Intermédica; 1997: 362-413.
41. PENA-CASANOVA J, AGUILAR M, BERTRÁN-SERRA I, SANTACRUZ P, HERNÁNDEZ G, INSA P. Normalización de los instrumentos de valoración cognitiva y funcional: (NORMACODEM): Objetivos, contenido y población. Neurología 1997; 12: 61-68.
42. PETERSEN RC, STEVENS JC, GANGULI M, TANGALOS EG, CUMMINGS JL, DEKOSKY ST. Practice parameter: Early detection of dementia: mild cognitive impairment: a evidence based review): Report of the Quality Standars Subcomité Academy of Neurology. Neurology 2001; 56: 1133-1142.
43. VILALTA-FRANCH J, LLINAS-REGLA J, LOPEZ-POUSA S. The Mini Cognitive Examination for screening in epidemiologic studies of dementia. Neurologia 1996; 11: 166-169.
44. Guidelines for the Support and Management of People with Dementia, 1998. New Zealand Guidelines Group (NZGG) [en línea] [Fecha de acceso: mayo 2002]. URL disponible en: http:/www.nzgg.org.nz/library/gl_complete/dementia/index.cfm#contents.
45. LOBO A, MARCOS G, DIA JL, DE LA CÁMARA C, VENTURA T, MORALES ASIN F et al. Validación y estandarización del mini-examen cognoscitivo (primera edición española del Mini-Mental Status Examination) en la población geriátrica general. Med Clin (Barc) 1999; 112: 767-774.
46. BRINK TL, YESAVAGE JA, LUM O et al. Screening tests for geriatric depression. Clin Gerontol 1982; 1: 37-43.
47. Short scales were as effective as long scales in screening for depression in older patients. ACP Journal Club. 2001; 135: 111.
48. POMEROY IM, CLARK CR, PHILP I. The effectiveness of very short scales for depression screening in elderly medical patients. Int J Geriatr Psychiatry 2001; 16: 321-326.
49. AGUADO C, MARTÍNEZ J, ONÍS MC et al. Adaptación y validación al castellano de la versión abreviada de la "Geriatric Depresión Scale" (GDS) de Yesavage. Aten Prim 2000; 26: 328.
50. FONSECA DEL POZO FJ, MARTÍNEZ DE LA IGLESIA J, RUBIO MV, ESPEJO J, ARANDA LARA JM, ENCISO BERGE I et al. Factores asociados a la alteración cognitiva en una población urbana. Proyecto ANCO. Aten Prim 1997; 20: 345-353.
51. MARÍN CARRASCO M, AYERDI NAVARRO MC, LEACHE BEORLEGUI T, IRIGOYEN ARA C, CORRALES GONZALEZ J, VALENCIA GIL MS et al. Síntomas depresivos y deterioro cognitivo global entre la población anciana atendida en un centro de atención primaria. Rev Esp Geriatr Gerontol 1993; 28: 135-141.
52. LÓPEZ-TORRES HIDALGO J, CERDÁ DÍAZ R, FERNÁNDEZ OLANO C, REQUENA GALLEGO M, FERNÁNDEZ CASALDERREY M, OTERO PUIME A. Factores asociados al consumo de medicación crónica en personas ancianas. Med Clin (Barc) 1997; 108: 572-576.
53. GONZÁLEZ DELGADO R, ZAPATA MUÑOZ JA, PÉREZ SÁNCHEZ JC, HORMIGO POZO A, GUERRERO ZAMORANO RD, BACA OSORIO A. Estudio del déficit cognitivo en pacientes ingresados en una residencia geriátrica. Med Gen 2001; 38: 792-796.
54. VILLAVERDE RUIZ, ML, FERNANDEZ LOPEZ L, GRACIA MARCO R, MORERA FUMERO A, CEJAS MÉNDEZ R. Salud mental en población institucionalizada mayor de 65 años en la isla de Tenerife. Rev Esp Geriatr Gerontol 2000; 35: 277-282.
55. GARCÍA SERRANO MJ, TOBÍAS FERRER J. Prevalencia de depresión en mayores de 65 años. Perfil del anciano de riesgo. Aten Prim 2001; 27: 484-488.
56. LÓPEZ GÓNZALEZ FM, CUENCA MONTERO M, VICIANA GARÓFANO D, RODRÍGUEZ MARTÍNEZ MI, MARTÍN LÓPEZ EM, ACOSTA FERRER M et al. Evaluación psicosocial de los ancianos de una zona básica de salud. SEMERGEN 2000; 26: 387-392.